Logo image of SPCB

SUPERCOM LTD (SPCB) Stock Fundamental Analysis

NASDAQ:SPCB - IL0010830961 - Common Stock

9.29 USD
+0.04 (+0.43%)
Last: 8/22/2025, 8:00:02 PM
9.25 USD
-0.04 (-0.43%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

4

Overall SPCB gets a fundamental rating of 4 out of 10. We evaluated SPCB against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While SPCB seems to be doing ok healthwise, there are quite some concerns on its profitability. SPCB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SPCB was profitable.
In the past 5 years SPCB reported 4 times negative net income.
SPCB had a negative operating cash flow in each of the past 5 years.
SPCB Yearly Net Income VS EBIT VS OCF VS FCFSPCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

SPCB has a Return On Assets (1.04%) which is comparable to the rest of the industry.
The Return On Equity of SPCB (1.90%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.04%
ROE 1.9%
ROIC N/A
ROA(3y)-8.43%
ROA(5y)-13.77%
ROE(3y)-105.34%
ROE(5y)-141.36%
ROIC(3y)N/A
ROIC(5y)N/A
SPCB Yearly ROA, ROE, ROICSPCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

SPCB's Profit Margin of 2.39% is fine compared to the rest of the industry. SPCB outperforms 61.29% of its industry peers.
SPCB has a Gross Margin of 48.43%. This is amongst the best in the industry. SPCB outperforms 83.87% of its industry peers.
In the last couple of years the Gross Margin of SPCB has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 2.39%
GM 48.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5Y4.68%
SPCB Yearly Profit, Operating, Gross MarginsSPCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

SPCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
SPCB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SPCB has more shares outstanding
The debt/assets ratio for SPCB has been reduced compared to a year ago.
SPCB Yearly Shares OutstandingSPCB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
SPCB Yearly Total Debt VS Total AssetsSPCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.33, we must say that SPCB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.33, SPCB is doing worse than 77.42% of the companies in the same industry.
A Debt/Equity ratio of 0.71 indicates that SPCB is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.71, SPCB is doing worse than 83.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -0.33
ROIC/WACCN/A
WACC6.91%
SPCB Yearly LT Debt VS Equity VS FCFSPCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 9.69 indicates that SPCB has no problem at all paying its short term obligations.
The Current ratio of SPCB (9.69) is better than 91.13% of its industry peers.
A Quick Ratio of 9.06 indicates that SPCB has no problem at all paying its short term obligations.
SPCB has a Quick ratio of 9.06. This is amongst the best in the industry. SPCB outperforms 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 9.69
Quick Ratio 9.06
SPCB Yearly Current Assets VS Current LiabilitesSPCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

SPCB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.19%, which is quite impressive.
Looking at the last year, SPCB shows a small growth in Revenue. The Revenue has grown by 4.01% in the last year.
The Revenue has been growing by 10.90% on average over the past years. This is quite good.
EPS 1Y (TTM)103.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.67%
Revenue 1Y (TTM)4.01%
Revenue growth 3Y31.09%
Revenue growth 5Y10.9%
Sales Q2Q%-5.37%

3.2 Future

SPCB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.66% yearly.
SPCB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.66% yearly.
EPS Next Y73.11%
EPS Next 2Y-6.39%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year-3.98%
Revenue Next 2Y11.43%
Revenue Next 3Y12.66%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SPCB Yearly Revenue VS EstimatesSPCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
SPCB Yearly EPS VS EstimatesSPCB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 100 150 200

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

SPCB is valuated correctly with a Price/Earnings ratio of 16.89.
87.90% of the companies in the same industry are more expensive than SPCB, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.24, SPCB is valued a bit cheaper.
SPCB is valuated correctly with a Price/Forward Earnings ratio of 14.93.
Based on the Price/Forward Earnings ratio, SPCB is valued cheaper than 85.48% of the companies in the same industry.
SPCB is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.89
Fwd PE 14.93
SPCB Price Earnings VS Forward Price EarningsSPCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.32% of the companies in the same industry are more expensive than SPCB, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.25
SPCB Per share dataSPCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y-6.39%
EPS Next 3Y0.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SPCB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUPERCOM LTD

NASDAQ:SPCB (8/22/2025, 8:00:02 PM)

After market: 9.25 -0.04 (-0.43%)

9.29

+0.04 (+0.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners12.44%
Inst Owner Change0%
Ins Owners4.78%
Ins Owner ChangeN/A
Market Cap38.09M
Analysts82.5
Price Target15.3 (64.69%)
Short Float %2.72%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)676.77%
Min EPS beat(2)-130.55%
Max EPS beat(2)1484.08%
EPS beat(4)2
Avg EPS beat(4)355.68%
Min EPS beat(4)-226.87%
Max EPS beat(4)1484.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.96%
Min Revenue beat(2)-4.3%
Max Revenue beat(2)-1.62%
Revenue beat(4)1
Avg Revenue beat(4)3.89%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)23.28%
Revenue beat(8)5
Avg Revenue beat(8)18.01%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)987.5%
EPS NY rev (1m)0%
EPS NY rev (3m)4150%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.87%
Valuation
Industry RankSector Rank
PE 16.89
Fwd PE 14.93
P/S 1.38
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.72
EV/EBITDA 17.25
EPS(TTM)0.55
EY5.92%
EPS(NY)0.62
Fwd EY6.7%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.74
BVpS8.48
TBVpS5.4
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.04%
ROE 1.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.39%
GM 48.43%
FCFM N/A
ROA(3y)-8.43%
ROA(5y)-13.77%
ROE(3y)-105.34%
ROE(5y)-141.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5Y4.68%
F-ScoreN/A
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 9.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.69
Quick Ratio 9.06
Altman-Z -0.33
F-ScoreN/A
WACC6.91%
ROIC/WACCN/A
Cap/Depr(3y)97.09%
Cap/Depr(5y)83.67%
Cap/Sales(3y)12.3%
Cap/Sales(5y)12.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.67%
EPS Next Y73.11%
EPS Next 2Y-6.39%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)4.01%
Revenue growth 3Y31.09%
Revenue growth 5Y10.9%
Sales Q2Q%-5.37%
Revenue Next Year-3.98%
Revenue Next 2Y11.43%
Revenue Next 3Y12.66%
Revenue Next 5YN/A
EBIT growth 1Y76.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year780.3%
EBIT Next 3Y136.88%
EBIT Next 5YN/A
FCF growth 1Y19.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.33%
OCF growth 3YN/A
OCF growth 5YN/A